Abstract. Pure 
. Somatomedin C (SM-C) has recently been shown to be identical to IGF I (Klapper et al. 1983 ). Due to their insulin-like structure, these growth factors possess insulin-like activity which, in contrast to insulin, is not abol¬ ished in the presence of insulin antibodies. They exert acute insulin-like effects on adipose tissue and muscle (Zapfet al. 1981a ), fibroblasts (Zapfet al. 1981a ), chondrocytes (Froesch et al. 1976 ) and calvaría cells (Canalis 1980; Schmid et al. 1983a) and the differentiation of cells of mensenchymal origin (Schmid et al. 1983b,c; Kurtz et al. 1982 ).
The levels of IGF I/SM-C and, to a lesser extent also those of IGF II in human serum depend on the growth hormone (GH) status (Furlanetto et al. 1977; Zapfet al. 1981b ). Recently, pure IGFI has been shown to stimulate growth in hypophysecto¬ mized (hypox) rats (Schoenle et al. 1982a ), a find¬ ing which strongly supports the somatomedin con¬ cept (Daughaday et al. 1972 ). Radioimmunoassaysfor human IGFI and IGF II They were performed as described earlier (Zapf et al. 1981b ). To separate IGF from the IGF carrier protein 0.5 ml serum samples were passed over a Sephadex G-50 (medium) column (1.5 x 100 cm) in 1 M acetic acid. The fractions eluting between 50 and 80% bed volume, devoid of IGF carrier protein, were lyophilized, washed in 2 ml of 0. Effects of IGF I and IGF II on growth indices (Fig. 3) 25 µ /ml (total µ /ml minus the 'background' activity of 39 µ /ml on the IGF I dose-responsive curves extrapolated through the 'saline points', left and middle panel of Fig. 3 ). This latter concentra¬ tion of IGF I would, however, not be expected to cause already a significant increase in body weight (right panel of Fig. 3) .
When the growth stimulating µ equivalents (as determined in the protein binding assay) of infused human IGF I and of endogenous rat IGF produced under the influence of GH are compared (Fig. 3) (Fig. 4) ). Thus hypoglycaemia is pre¬ vented.
Although growth appears to be brought about mainly by IGF, GH may be an important modula¬ tor of IGF action. One of the possibilities of acting as a modulator is via its control of IGF binding proteins (Fig. 4) . The glucose transport system in adipose cells is also modulated by GH ), but not by infused human IGFI or II (Schoenle et al. 1983 ). Therefore, this latter in vivo effect of GH does not appear to be mediated by IGF.
The results of the present study support the concept that IGF I/SM-C is the major human soma¬ tomedin. The main role of IGFII, a much less potent growth factor, remains to be elucidated. GH is one of the major regulatory factors for the synthesis of IGF (Schwander et al. 1983) , and it may modulate the effects of IGF on its target tissues.
